What is Healius Limited (HLS) Stock Price?
The live share price and session change for Healius Limited (HLS) are shown in the TradingView quote on this page.
HLS Stock Price, Valuation & Chart | Healius Limited
HLS Historical price chart
HLS Key Stats
Fair Value
Disclaimer
Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.
Market Capitalization308.62M
PE Ratio-2.07
EPS-0.21
Trading Volume5.82M
Today's High/Low0.43/0.41
Dividend Yield0.00
52 Week High/Low1.07/0.3
Shares Outstanding726.16M
HLS Financial Statement
HLS Analyst ratings
Sell
Strong buy
0
Buy
1
Hold
4
Sell
2
Strong sell
3
Based on 10 analysts giving stock ratings to HLS in the past 3 months.
HLS Analysis & performance metrics
HLS Company profile
Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia. The company operates through four segments: Pathology, Imaging, Day…
HLS Management team
Name
Position
John McKechnie
Advisor
Jon Eide
Group Executive of Commercial & Customer
Paul D. Anderson B.Com., C.A.CEO
MD, Chief Executive Officer & Director
Stephen Humphries B.Sc.CFO
Chief Financial Officer& Company Secretary
Ian McphanCOO
Chief Operating Officer of Healius Pathology
Jan Van Rooyen
Head & Group Executive of Healius Pathology
Sharon Ng
Head of Group FP&A
Paula Bayliss
Group Executive of People & Culture
Name
Position
John McKechnie
Advisor
Jon Eide
Group Executive of Commercial & Customer
Paul D. Anderson B.Com., C.A.CEO
MD, Chief Executive Officer & Director
Stephen Humphries B.Sc.CFO
Chief Financial Officer& Company Secretary
Ian McphanCOO
Chief Operating Officer of Healius Pathology
Jan Van Rooyen
Head & Group Executive of Healius Pathology
Sharon Ng
Head of Group FP&A
Paula Bayliss
Group Executive of People & Culture
Management Team
John McKechnie
Advisor
Jon Eide
Group Executive of Commercial & Customer
Paul D. Anderson B.Com., C.A.CEO
MD, Chief Executive Officer & Director
Stephen Humphries B.Sc.CFO
Chief Financial Officer& Company Secretary
Ian McphanCOO
Chief Operating Officer of Healius Pathology
Jan Van Rooyen
Head & Group Executive of Healius Pathology
Sharon Ng
Head of Group FP&A
Paula Bayliss
Group Executive of People & Culture
Management
John McKechnie
Advisor
Jon Eide
Group Executive of Commercial & Customer
Paul D. Anderson B.Com., C.A.CEO
MD, Chief Executive Officer & Director
Stephen Humphries B.Sc.CFO
Chief Financial Officer& Company Secretary
Ian McphanCOO
Chief Operating Officer of Healius Pathology
Jan Van Rooyen
Head & Group Executive of Healius Pathology
Sharon Ng
Head of Group FP&A
Paula Bayliss
Group Executive of People & Culture
Total 8 executives
HLS Frequently asked questions
Why is the Healius Limited (HLS) stock price going up or down today?
The stock price of Healius Limited (HLS) can change with earnings, company news, and overall market sentiment. Healius Limited operates in the Healthcare / Medical - Diagnostics & Research market, so sector-wide moves can also affect the share price. Use the live TradingView quote on this page together with the chart and key stats.
Is the Healius Limited stock expensive at its current price?
Whether Healius Limited looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for HLS on this page is -2.07. EPS on this page is -0.21. Compare those figures with peers and growth expectations before deciding if the current Healius Limited price is justified.
How has the stock price of Healius Limited (HLS) performed historically?
Historical performance for Healius Limited (HLS) is shown on the price chart on this page. Review multi-period moves alongside volume to see how HLS reacted to past earnings and market events.
Should I buy Healius Limited (HLS) stock, at this price?
Buying Healius Limited (HLS) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.